A research team synthesized and determined the structure of a borate-linked 3D crystalline covalent organic framework, ...

An international team of researchers has found a way to create 2D nanosheets in which the molecules in the layers are bound only by weak, non-covalent bonds. In their paper published in the journal ...

Structural complexity in modern small molecules is reshaping what drug development partners must deliver from discovery through commercial supply.Targeted protein degraders, covalent agents, and a new ...

Misbehaving proteins are behind many diseases. One way drugmakers incapacitate these bad actors is to deploy molecules that bind to them. But finding solid footholds on the proteins to block their ...

Terremoto Biosciences has launched with $75 million in series A financing to discover small-molecule drugs using its lysine-targeted covalency technology. Terremoto says most drugs that bind to ...

Molly Gibson, PhD, has focused her attention on building companies at the intersection of AI and life sciences for the past decade, having co-founded both Generate: Biomedicines and Lila Sciences.

Collaboration pairs PerkinElmer's ICP-MS/MS and LC-MS/MS technologies with Covalent's failure analysis expertise to help manufacturers pinpoint the root causes of material failure and performance ...

The structural organization of food at the nanoscale plays a pivotal role in determining the macroscopic properties, nutritional profile, and sensory ...